Krka DD (WAR:KRK) Cyclically Adjusted Revenue per Share: zł266.98 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:KRK Krka DD WAR:KRK
94 GF Score
Price zł1,148.00
GF Value zł825.57
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krka DD Cyclically Adjusted Revenue per Share?

Krka DD WAR:KRK -1.03% 94 Cyclically Adjusted Revenue per Share is zł266.98 as of Jun. 2026. GuruFocus rates WAR:KRK with a GF Score™ of 94/100 and a GF Value™ of zł825.57 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Krka DD's adjusted revenue per share for the three months ended in Jun. 2026 was zł85.909. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł266.98 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Krka DD's average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Krka DD was 6.60% per year. The lowest was 5.70% per year. And the median was 6.15% per year.

As of today (2026-08-29), Krka DD's current stock price is zł1148.00. Krka DD's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was zł266.98. Krka DD's Cyclically Adjusted PS Ratio of today is 4.30.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Krka DD was 4.34. The lowest was 1.73. And the median was 2.47.


Krka DD  (WAR:KRK) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Krka DD's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1148.00/266.98
=4.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Krka DD was 4.34. The lowest was 1.73. And the median was 2.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Krka DD Cyclically Adjusted Revenue per Share Related Terms


Krka DD Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Krka DD's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krka DD Cyclically Adjusted Revenue per Share Chart

Krka DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 213.47 235.94 231.18 234.19 249.40

Krka DD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 247.58 251.42 249.40 260.61 266.98

WAR:KRK vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Krka DD's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka DD Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka DD's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Krka DD's Cyclically Adjusted PS Ratio falls into.


WAR:KRK
94GF Score
Krka DD WAR:KRK
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krka DD Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Krka DD's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=85.909/333.9520*333.9520
=85.909

Current CPI (Jun. 2026) = 333.9520.

Krka DD Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 32.369 241.428 44.774
201612 39.169 241.432 54.179
201703 39.795 243.801 54.510
201706 43.651 244.955 59.510
201709 37.808 246.819 51.155
201712 46.809 246.524 63.409
201803 48.587 249.554 65.019
201806 46.912 251.989 62.171
201809 39.730 252.439 52.559
201812 48.222 251.233 64.099
201903 50.977 254.202 66.970
201906 51.625 256.143 67.307
201909 43.411 256.759 56.462
201912 51.006 256.974 66.285
202003 60.875 258.115 78.761
202006 45.734 257.797 59.244
202009 50.188 260.280 64.394
202012 54.554 260.474 69.943
202103 56.526 264.877 71.267
202106 59.674 271.696 73.348
202109 52.180 274.310 63.525
202112 52.854 278.802 63.309
202203 57.458 287.504 66.741
202206 54.092 296.311 60.963
202209 45.927 296.808 51.675
202212 60.826 296.797 68.441
202303 59.270 301.836 65.576
202306 60.737 305.109 66.479
202309 54.303 307.789 58.919
202312 61.488 306.746 66.942
202403 64.285 312.332 68.735
202406 65.305 314.175 69.416
202409 60.804 315.301 64.401
202412 60.573 315.605 64.094
202503 69.078 319.799 72.135
202506 74.513 322.561 77.144
202509 69.816 324.800 71.783
202512 73.299 324.054 75.538
202603 74.779 330.213 75.626
202606 85.909 333.952 85.909

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of zł266.98 mean?
Krka DD (WAR:KRK) has a Cyclically Adjusted Revenue per Share of zł266.98 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Krka DD and its competitors.
Is Krka DD's Cyclically Adjusted Revenue per Share too high?
Krka DD's current Cyclically Adjusted Revenue per Share is zł266.98. Overall, Krka DD has a GF Score™ of 94/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krka DD's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Krka DD's Cyclically Adjusted Revenue per Share of zł266.98 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Krka DD and its competitors. Krka DD's current Cyclically Adjusted Revenue per Share is zł266.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krka DD stock overvalued right now?
Based on GuruFocus' analysis, Krka DD (WAR:KRK) is currently considered Significantly Overvalued. The stock's GF Value™ is zł825.57, compared to a current price of zł1,148.00 — trading 39.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is zł266.98. Krka DD's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Krka DD (WAR:KRK), the current Cyclically Adjusted Revenue per Share is zł266.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krka DD (WAR:KRK) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of zł1,148.00 is trading 39.1% above its estimated GF Value™ of zł825.57. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for WAR:KRK:

  • Cyclically Adjusted Revenue per Share: zł266.98
  • GF Value™: zł825.57 vs. price of zł1,148.00 (39.1% above fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the WAR:KRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
94GF Score

Get the complete analysis for WAR:KRK

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł1,148.00
Price
zł825.57
GF Value